Evidence for arylamine N-acetyltransferase activity in the fungi Candida albicans

Toxicology Letters

Volumn 92, Issue 2, 1997, Pages 109-116

  Fang, S H ^a   Chung, J G ^a   Chang, W C ^a   Chang, S S ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

2 Aminofluorene; Candida albicans; N Acetyl 2 aminofluorene; N Acetyltransferase

Indexed keywords

2 FLUORENYLAMINE; 4 AMINOBENZOIC ACID; ARYLAMINE ACETYLTRANSFERASE; IODOACETAMIDE;

ACETYLATION; ARTICLE; CANDIDA ALBICANS; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME SPECIFICITY; NONHUMAN; PRIORITY JOURNAL;

4-AMINOBENZOIC ACID; ARYLAMINE N-ACETYLTRANSFERASE; CANDIDA ALBICANS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOSOL; FLUORENES; HYDROGEN-ION CONCENTRATION; KINETICS; TEMPERATURE;

CANDIDA ALBICANS; FUNGI;

EID: 0030802386     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(97)00037-4     Document Type: Article

References (25)

1. Andres, H.H., Weber, W.W., 1986. N-acetylation pharmacogenetics: Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo. Drug. Metal Dispos. 14, 382-385.
2. Benveniste, R., Davies, J., 1973a. Mechanisms of antibiotic resistance in bacteria. Ann. Rev. Biochem. 42, 471-526.
3. Blum, M., Grant, D.M., McBride, O.W., Heim, M., Myer, U.A., 1990. Human arylamine N-acetyltransferase genes: isolation, characterization, chromosomal localization, and functional expression. DNA Cell Biol. 9, 193-203.
4. Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. Cartwright, R.A., Glasham, R.W., Rogers, H.J., Ahmad, R.A., Barham-Hall, D., Higgins, E.M., Kaha, A., 1982. The role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer. Lancet. 2, 842-846.
6. s slow acetylator congenic mice. Drug Metabol. Dispos. 21, 10571663.
7. Chung, J.G., Kuo, H.M., Lin, T.H., Ho, C.C., Lee, J.H., Lai, J.M., Levy, G.N., Weber, W.W., 1996. Evidence for arylamine N-acetyltransferase in the nematode Anisakis simplex. Cancer Lett. 106, 1-8.
8. Cleland, W.W., 1967. The statistical analysis of enzyme kinetics data. Adv. Enzymol. 29, 1-32.
9. Deguchi, T., Sakamoto, Y., Sasaki, Y., Uyemura, K., 1990. Arylamine Nacetyltransferase form chicken liver. I. Monoclonal antibodies, immunoaffinity purification, and amino acid sequences. J. Biol. Chem. 263, 4630-4634.
10. Drayer, D.E., Strors, J.M., Jones, B., Sandler, A., Reidenberg, M.M., 1974. In vitro acetylation of drugs by human blood cells. Drug. Metab. Dispos. 2, 499-505.
11. Hein, D.W., Kirlin, W.G., Ferguson, R.J., Weber, W.W., 1985. Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamster. J. Pharmacol. Exp. Ther. 234, 358-364.
12. Ho, C.C., Lin, T.H., Lai, Y.S., Chung, J.G., Levy, G.N., Weber, W.W., 1996. Kinetics of acetyl coenzyme A: arylamine N-acetyltransferase from rapid and slow acetylator frog tissues. Drug Metabol. Dispos. 24, 137-141.
13. Ilett, K.K., David, B.M., Detchon, P., Castledon, W.M., Kwa, R., 1987. Acetylator phenotype in colorectal carcinoma. Cancer Res. 47, 1466-1469.
14. Kamitani, K., Sakiyama, F., 1991. Hen oviduct N-alpha-acetyltransferase is a ribonucleoprotein having 7 s R N A. J. Biol. Chem. 264, 13188-13193.
15. Kilbane, A.J., Petroff, T., Weber, W.W., 1985. Michaelismenten constants for arylamine drugs in rapid and slow human acetylator liver. FASEB. J. 2, A1140.
16. Lee, F.J.S., Lin, L.W., Smith, J.A., 1988. Purification and characterization of an N-acetyltransferase from Saccharomyces cerevisiae. J. Biol. Chem. 263, 1494814955.
17. Levy, G.N., Chung, J.G., Weber, W.W., 1994. 2-Aminofluorene metabolism and DNA adduct formation by mononuclear leukocytes from rapid and slow acetylator mouse strains. Carcinogenesis. 15, 353-357.
18. Manning, B.W., 1986. Biotransformation of i-nitropyrene to 1-aminopyrene and N-formyl-1-aminopyrene to 1 -aminopyrene by rat intestinal bacteria. Carcinogenesis 4, 339-346.
19. Melick, W.F., Naryka, J.J., Kelly, R.E., 1971. Bladder cancer due to exposure to para-aminobiphenyl. A 17-year follow up. J. Urol. 106, 220-226.
20. Okumura, F., Ueda, O., Kitamura, S., Tastsumi, K., 1995. N-acetylation and N-formylation of carcinogenic arylamines and related compounds in dogs. Carcinogenesis. 16, 71-76.
21. Saito, K.A., Shinohara, A., Kamataki, T., Kato, R., 1985. Metabolic activation of mutagenic N-hydroxyarylamines by O-acetyltransferase in Salmonella typhimurium TA98. Arch. Biochem. Biophys. 239, 286-295.
22. Shirai, T., Fysh, J.M., Lee, M.S., Vaught, J.B., King, C.M., 1981. Relationship of metabolic activation of N-hydroxyN-acylarylamines to biological response in the liver and mammary gland of the female CD rat. Cancer Res. 41, 4346-4353.
23. Vatsis, K.P., Martell, K.J., Weber, W.W., 1991. Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc. Natl. Acad. Sci. USA 88, 6333-6337.
24. Weber, W.W., 1987. The Acetylator Genes and Drug Response, Oxford University press, New York.
25. Yamada, R., Bradshaw, R.A., 1991. Rat liver polysome N-acetyltransferase: isolation and characterization. Biochemistry 30, 1010-1016.